Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment by Olechnowicz, SWZ, Weivoda, MM, Lwin, ST, Leung, SK, Gooding, S, Nador, G, Javaid, MK, Ramasamy, K, Rao, SR, Edwards, JR, Edwards, CM

Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs by Kolovos, S, Nador, G, Kishore, B, Streetly, M, Rabin, N, Chantry, A, Yong, K, Ashcroft, J, Bowcock, S, Drayson, M, Ramasamy, K, Prieto Alhambra, D, Cooper, C, Javaid, M, Pinedo Villanueva, R

Elective vs non-elective hospital admissions by patients with multiple myeloma in England 2014 - 2018 by Ramasamy, K, Kolovos, S, Nador, G, Finley, R, Streetly, M, Kishore, B, Rabin, N, Chantry, A, Yong, K, Ashcroft, J, Bowcock, S, Drayson, M, Prieto Alhambra, D, Cooper, C, Javaid, M, Pinedo Villanueva, R

Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers by Agarwal, G, Nador, G, Varghese, S, Getu, H, Palmer, C, Rodgers, C, Pereira, C, Sallemi, G, Partington, K, Patel, N, Soundarajan, R, Mills, R, Brouwer, R, Shah, A, Peppercorn, D, Edwards, C, Javaid, M, Gooding, S, Ramasamy, K

Prospective assessment of tumour burden and bone disease in plasma cell dyscrasias using DW-MRI and exploratory bone biomarkers by Agarwal, G, Nador, G, Varghese, S, Getu, H, Palmer, C, Watson, E, Pereira, C, Sallemi, G, Partington, K, Patel, N, Soundarajan, R, Mills, R, Brouwer, R, Maritati, M, Shah, A, Peppercorn, D, Oppermann, U, Edwards, CM, Rodgers, CT, Javaid, MK, Gooding, S, Ramasamy, K